FDA approves RSV vaccine for newborns
Pfizer's Abrysvo vaccine would be given to pregnant women, who then pass the antibodies to their newborns. CBS News Bay Area anchor Ryan Yamamoto asks Dr. Malathi Srinivasan, Stanford Clinical Professor of Medicine, how the vaccine works, how effective it is, and if it's safe.